- Kim JM, Yang YS, Park KH, Ge XP, Xu R, Li N, Song MY, Chun HH, Bok SY, Charles JF, Fihl-Cochet O, Boldyreff B, Dinter D, Yu PB, Kon N, Gu W, Takarad T, Greenblatt MB, Shim JH. A novel RUNX2 Stabilization Pathway Mediates Physiologic and Pathologic Bone Formation. Nat Commun. 2020 May 8;11(1):2289. PDF
- Dey D, Bagarova J, Hatsell SJ, Armstrong K, Huang L, Ermann J, Vonner AJ, Shen Y, Mohedas AH, Lee A, Eekhoff EMW, van Schie A, Demay MB, Keller C, Wagers AJ, Economides AN, Yu PB. Two Tissue-Resident Progenitor Lineages Drive Distinct Phenotypes of Heterotopic Ossification. Science Translational Medicine. 2016 Nov 23;8(366):366ra163. PDF
- Hatsell SJ, Idone V, Alessi-Wolken DM, Huang L, Kim HJ, Wang L, Wen XL, Nannuru KC, Jimenez J, Xie L, Makhoul G, Chernomorsky R, D’Ambrosio D, Corpina RA, Schoenherr C, Feeley K, Yu PB, Yancopoulos GD, Murphy AJ, Economides AN. ACVR1R206H Receptor Mutation Causes Fibrodysplasia Ossificans Progressiva by Gaining Responsiveness to Activin A. Science Translational Medicine, 2015 Sep; 7(303): 303ra137. *Accompanying Editorial in Science. PDF
- Yu PB, Donna Y. Deng, Carol S. Lai, Charles C. Hong, Gregory D. Cuny, Mary L. Bouxsein, Deborah W. Hong, Patrick M. McManus, Takenobu Katagiri, Chetana Sachidanandan, Nobuhiro Kamiya, Tomokazu Fukuda, Yuji Mishina, Randall T. Peterson, and Kenneth D. Bloch. BMP Type I Receptor Inhibition Prevents Ectopic Ossification in a Mouse Model of Fibrodysplasia Ossificans Progressiva. Nature Medicine. 2008; 14(12): 1363-9. PDF